US Stock MarketDetailed Quotes

FBRX Forte Biosciences

Watchlist
  • 21.710
  • +1.920+9.70%
Close Nov 29 13:00 ET
  • 21.710
  • 0.0000.00%
Post 17:01 ET
31.74MMarket Cap-1325P/E (TTM)

About Forte Biosciences Company

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.

Company Profile

SymbolFBRX
Company NameForte Biosciences
Listing DateApr 13, 2017
Issue Price10.00
Founded2017
CEODr. Paul A. Wagner, PhD
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address3060 Pegasus Park Drive,Building 6
CityDallas
ProvinceTexas
CountryUnited States of America
Zip Code75247
Phone1-310-618-6994
Websitehttp://www.fortebiorx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Paul A. Wagner, PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 1.45M
  • Antony A. Riley
  • Chief Financial Officer
  • 722.98K
  • Dr. Barbara K. Finck, M.D.
  • Director
  • 61.73K
  • Dr. Scott C. Brun, M.D.
  • Independent Director
  • 62.73K
  • Dr. Lawrence Eichenfield, M.D.
  • Independent Director
  • 62.73K
  • Steven Kornfeld
  • Independent Director
  • 97.73K
  • Donald A. Williams
  • Independent Director
  • 85.73K
  • Dr. Stephen K. Doberstein, PhD
  • Independent Director
  • 62.73K
  • David W. Gryska, M.B.A.
  • Independent Director
  • 104.30K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data